PARP

Cat. No.

A28973

CAS No.

63916-38-1

NU1064 dihydrochloride

NU1064 dihydrochloride is a selective inhibitor of poly(ADP-ribose) polymerase (PARP), an enzyme involved in DNA repair mechanisms. This compound enhances the cytotoxic effects of DNA-methylating agents, such as MTIC, in a concentration-dependent manner. It is valuable for research in cancer biology, particularly in studies focusing on enhancing the efficacy of chemotherapeutic agents and understanding mechanisms of DNA repair inhibition.

Cat. No.

A28974

CAS No.

623578-11-0

KU-0058684

KU-0058684 is a selective PARP inhibitor, exhibiting an IC50 of 3.2 nM for PARP-1. This reagent effectively impairs DNA double strand break repair, making it a valuable tool for investigating DNA damage response mechanisms. Its application extends to studying the therapeutic potential of PARP inhibition in various cancer models.

Cat. No.

A28976

CAS No.

283172-68-9

WD2000-012547

WD2000-012547 is a selective inhibitor of poly(ADP-ribose) polymerase-1 (PARP-1), demonstrating a pKi value of 8.221. This compound effectively interferes with PARP-1 activity, which plays a crucial role in DNA repair and cellular response to DNA damage. WD2000-012547 is instrumental in research applications involving cancer therapeutics, where modulation of DNA repair pathways is of significant interest.

Cat. No.

A28977

CAS No.

1023814-45-0

OUL245

OUL245 is a selective inhibitor of PARP2, exhibiting an IC50 of 44 nM. It also demonstrates inhibitory activity against other PARP family members and TNKS enzymes, with IC50 values ranging from 2.9 to 8.8 μM. This compound is valuable for research into DNA repair mechanisms and the therapeutic potential of targeting PARP enzymes in various cancer models.

Cat. No.

A28978

CAS No.

93117-07-8

5-AIQ hydrochloride

Synonyms: 5-Aminoisoquinolin-1-one hydrochloride

5-AIQ hydrochloride is a selective inhibitor of PARP-1, an important enzyme involved in DNA repair. This compound exhibits protective effects against ischemia-reperfusion injury in liver tissue, making it a valuable tool for studying conditions related to hepatic ischemia-reperfusion. Its applications extend to research focused on oxidative stress and cell survival mechanisms, providing insights into potential therapeutic strategies for liver protection.

Cat. No.

A28979

CAS No.

3033649-17-8

PARP1-IN-22

PARP1-IN-22 is a highly potent inhibitor of poly (ADP-ribose) polymerase 1 (PARP1) with an IC50 of less than 10 nM. This compound is utilized in research focused on DNA damage repair pathways and cellular responses to oxidative stress. Its ability to inhibit PARP1 makes it valuable for studies in cancer therapy and neurodegenerative diseases, where modulation of DNA repair mechanisms is crucial.

Cat. No.

A28980

CAS No.

943650-25-7

A-620223 succinate

Synonyms: ABT-472

A-620223 succinate is a potent inhibitor of poly(ADP-ribose) polymerase (PARP), targeting the PARP-1 enzyme with a Ki value of 8 nM and an EC50 value of 3 nM in cellular assays. Its excellent selectivity and bioavailability make it an invaluable tool for cancer research, enabling investigations into DNA repair mechanisms and potential therapeutic strategies. This compound is particularly useful in studies focused on the efficacy of PARP inhibition in various cancer models.

Cat. No.

A28982

CAS No.

3064731-00-3

PARP14 inhibitor 2

PARP14 Inhibitor 2 is a highly selective inhibitor targeting PARP14 with an IC50 value of less than 30 nM. This compound effectively inhibits the mono-ADP-ribosyltransferase activity of PARP14, thereby modulating signaling pathways associated with IFN-γ and IL-4. By reversing protumor macrophage polarization and inhibiting pro-inflammatory responses, PARP14 Inhibitor 2 holds promise for the investigation of diseases related to PARP14, including tumors, atopic dermatitis, and autoimmune disorders.

Cat. No.

A28983

CAS No.

1606996-12-6

PARP1-IN-36

PARP1-IN-36 is a selective inhibitor of PARP-1, characterized as a 4-carboxamido-isoindolinone derivative with a Kd value of less than 0.01 μM. This compound exhibits significant biological activity in the modulation of cellular processes associated with DNA repair, making it a valuable tool in research focused on cancer, cardiovascular diseases, nervous system injury, and inflammation. Its potent inhibition of PARP-1 serves to elucidate the role of this enzyme in various pathological contexts.

Cat. No.

A28984

CAS No.

1015-89-0

6(5H)-Phenanthridinone

6(5H)-Phenanthridinone is a potent inhibitor of PARP-1, a key enzyme involved in DNA repair processes. This compound exhibits significant immunomodulatory effects and has been shown to inhibit cell proliferation. It is employed in cancer research to explore therapeutic strategies targeting DNA repair pathways and to enhance the efficacy of chemotherapeutic agents.

Cat. No.

A28985

CAS No.

3032451-58-1

PARP1/2-IN-3

PARP1/2-IN-3 is a potent inhibitor of PARP1 and PARP2, exhibiting IC50 values of 0.2235 nM and

Cat. No.

A28987

CAS No.

116764-24-0

UNPD139734

UNPD139734 is a potent inhibitor of Cyclin-Dependent Kinase 1 (CDK-1) and Poly (ADP-ribose) polymerase 1 (PARP-1), forming stable complexes with both target proteins. This compound serves as a valuable lead for the structural optimization of dual-target anticancer agents, particularly in the context of breast cancer research. Its dual inhibition mechanism offers a promising avenue for investigating novel therapeutic strategies in oncology.

Cat. No.

A28988

CAS No.

3034665-49-8

PARP-1/2/7-IN-1

PARP-1/2/7-IN-1 is a highly potent inhibitor of poly (ADP-ribose) polymerases PARP-1, PARP-2, and PARP-7, demonstrating an IC50 of less than 10 nM. This compound is valuable for research applications focused on cancer biology, DNA repair mechanisms, and cellular stress responses. Its multifunctional inhibition can aid in the exploration of therapeutic strategies targeting PARP-mediated pathways in various diseases.

Cat. No.

A28989

CAS No.

3085256-81-8

PARP1-IN-48

PARP1-IN-48 is a potent and selective inhibitor of poly(ADP-ribose) polymerase 1 (PARP1), exhibiting an IC50 of 3 nM against PARP1 and 170 nM against PARP2. This compound is valuable for research in oncology, virology, and metabolic disorders, facilitating investigations into the role of PARP1 in DNA repair and cellular stress responses. Its selective action makes it an essential tool for studying therapeutic pathways in cancer treatment and other disease models.

Cat. No.

A28990

CAS No.

908803-38-3

PARP1-IN-30

PARP1-IN-30 is a potent, selective inhibitor of PARP1 that exhibits cytotoxic effects in tumor cells. It effectively targets cancer cells with deficiencies in the breast cancer 1 protein (BRCA1) or BRCA2, offering a valuable tool for elucidating the role of PARP1 in DNA repair and cancer biology. This compound is particularly relevant for research applications focused on targeted cancer therapies and synthetic lethality in oncology.

Cat. No.

A28991

CAS No.

1708103-69-8

ARTD10/PARP10-IN-2

ARTD10/PARP10-IN-2 is a potent and non-selective inhibitor of the poly(ADP-ribose) polymerases, specifically targeting ARTD10/PARP10 and ARTD1/PARP1. With IC50 values of 2.0 μM and 9.7 μM, respectively, this compound effectively modulates mono-ADP-ribosyltransferase and poly(ADP-ribose) polymerase activities. Its ability to inhibit these pathways makes ARTD10/PARP10-IN-2 valuable for research on DNA repair mechanisms and therapeutic approaches in cancer treatment.

Cat. No.

A28992

CAS No.

1424500-13-9

ZINC000081009201

ZINC000081009201 is a potent inhibitor of poly(ADP-ribose) polymerase 1 (PARP1) with an IC50 value of 1.4767 μM. This compound demonstrates significant potential for the study of triple-negative breast cancer (TNBC) by targeting PARP1-mediated repair pathways. Its inhibition may aid in elucidating the mechanisms of resistance and sensitivity in cancer treatment, making it a valuable tool for cancer research applications.

Cat. No.

A28993

CAS No.

2819999-00-1

PARP7-IN-18

PARP7-IN-18 is a potent selective inhibitor of PARP7, exhibiting an IC50 value of 0.11 nM. This compound demonstrates significant anticancer activity, making it a valuable tool for research applications focused on cancer biology and the therapeutic potential of targeting PARP7. Its favorable pharmacokinetic properties further enhance its utility in in vivo studies and drug development.

Cat. No.

A28994

CAS No.

188106-83-4

NU 1085

NU 1085 is a potent poly(ADP-ribose) polymerase (PARP) inhibitor with an impressive Ki of 6 nM. This compound exhibits significant cytotoxicity towards cancer cells, with an LC50 between 83-94 μM. Additionally, NU 1085 has the potential to enhance the anticancer effects of Temozolomide, making it a valuable tool for cancer research, particularly in the study of lung cancer and other malignancies.

Cat. No.

A28995

CAS No.

2659357-95-4

PARP1-IN-20

PARP1-IN-20, a selective PARP1 inhibitor, exhibits a potent inhibitory effect with an IC50 of 4.62 nM. This compound demonstrates minimal PARP-Trapping activity compared to other known inhibitors, including a significant threshold of >100 μM in the MDA-MB-436 cell line. PARP1-IN-20 is suitable for research applications focused on cancer therapy and DNA damage repair mechanisms.

Cat. No.

A28996

CAS No.

3047557-92-3

ADP-ribose/PARP-IN-1

ADP-ribose/PARP-IN-1 is a conjugated compound that combines disease-targeting moieties with PARP inhibitor functionality. This reagent selectively delivers PARP inhibitors to tumor cells, facilitating the inhibition of PARP enzymes that are critical for DNA damage repair. The presence of a cleavable linker ensures the release of the PARP inhibitor under specific conditions, while the chelator component enables the accumulation of radionuclides that exert cytotoxic effects. ADP-ribose/PARP-IN-1 is a valuable tool for research into prostate cancer and other malignancies characterized by PARP dependency.

Cat. No.

A28997

CAS No.

1207456-03-8

LT-626

LT-626 is a potent poly(ADP-ribose) polymerase (PARP) inhibitor, with an IC50 of 1.60 nM. This inhibitor effectively reduces cellular poly(ADP-ribose) synthesis, demonstrating an EC50 of 17.9 nM, and displays enhanced cytotoxicity in colorectal cancer cells with MRE11 mutations. Additionally, LT-626 exhibits synergistic effects when combined with chemotherapeutic agents such as Cisplatin, Oxaliplatin, and SN-38, making it a valuable tool for colorectal cancer research applications.

Cat. No.

A28998

CAS No.

1613436-03-5

TNKS-2-IN-4

TNKS-2-IN-4 is a selective inhibitor of TNKS-2, demonstrating an IC50 of 19 nM. This compound exhibits significant anticancer activity specifically against colorectal cancer, making it a valuable tool for research in cancer biology and therapeutic development. Its selective inhibition of TNKS-2 highlights its potential for studying the mechanisms of tumor progression and treatment responses.

Cat. No.

A28999

CAS No.

2379390-80-2

RBN010860

RBN010860 is a potent inhibitor of PARP7, exhibiting an IC50 value of less than 0.1 μM. This reagent serves as a valuable tool for investigating the role of PARP7 in cancer biology, enabling researchers to explore its potential as a therapeutic target in oncological studies.

Cat. No.

A29000

CAS No.

2819700-92-8

PARP7-IN-12

PARP7-IN-12 is a potent inhibitor of PARP7, exhibiting an IC50 value of 7.836 nM. This compound demonstrates significant potential in cancer research by modulating poly(ADP-ribose) polymerase activity, which is associated with DNA damage response pathways. PARP7-IN-12 may serve as an effective tool for elucidating the role of PARP7 in tumor biology and for developing therapeutic strategies targeting PARP-related pathways in cancer.